【Diamond Biofund】March 2026 Revenue -NT$0.085 Billion (YoY +86.9%)
Diamond Biofund (6901), which invests in the biotech sector, reported a negative monthly revenue of -NT$0.085 billion for March 2026. However, this represents an +86.9% improvement year-over-year, meaning the loss was significantly reduced.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: April 12, 2026 at 16:30 (1015h 30m after Published)
- 🤖 AI Analyzed: April 13, 2026 at 11:13 (18h 43m after Collected)
Company Code: 6901
Company Name: Diamond Biofund
Industry: Other
Data Month: 2026-03
Monthly Revenue: -84,898 thousand NTD (-0.085 billion)
Year-on-Year Change: +86.9%
Company Name: Diamond Biofund
Industry: Other
Data Month: 2026-03
Monthly Revenue: -84,898 thousand NTD (-0.085 billion)
Year-on-Year Change: +86.9%
FAQ
What was Diamond Biofund's revenue for March 2026?
Diamond Biofund's revenue for March 2026 was -84,898 thousand NTD, which is equivalent to -0.085 billion NTD.
How did Diamond Biofund's revenue in March 2026 compare to the previous year?
Diamond Biofund's revenue in March 2026 showed a significant year-on-year increase of +86.9%.
What is the company code for Diamond Biofund?
The company code for Diamond Biofund is 6901.
In which industry is Diamond Biofund classified?
Diamond Biofund is classified under the 'Other' industry sector.
What was the specific monthly revenue figure reported for March 2026 by Diamond Biofund?
The specific monthly revenue figure reported for March 2026 by Diamond Biofund was -84,898 thousand NTD.